Analysis & commentary independent review of social and population variation in mental health could improve diagnosis in DSM revisions

Health Affairs

Volumn 32, Issue 5, 2013, Pages 984-993

  Hansen, Helena B ^a   Donaldson, Zoe ^b   Link, Bruce G ^b   Bearman, Peter S ^b   Hopper, Kim ^c   Bates, Lisa M ^b   Cheslack Postava, Keely ^b   Harper, Kristin ^b   Holmes, Seth M ^d   Lovasi, Gina ^c   Springer, Kristen W ^e   Teitler, Julien O ^b  

^a NEW YORK UNIVERSITY   (United States)

^b Howard Hughes Medical Institute   (United States)

^c Mailman School of Public Health   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CULTURAL ANTHROPOLOGY; DRUG MARKETING; DSM-5; ENVIRONMENTAL FACTOR; ETHNICITY; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; MENTAL DISEASE; MENTAL HEALTH; POSTTRAUMATIC STRESS DISORDER; RACE; REIMBURSEMENT; SEX DIFFERENCE; SEXUAL ORIENTATION; SOCIAL ASPECT; SOCIAL SECURITY; SOCIAL STATUS; ADVISORY COMMITTEE; CLASSIFICATION; DETERMINANTS OF HEALTH; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUSTRY; HEALTH REFORM; INTERDISCIPLINARY EDUCATION; INTERNATIONAL/GLOBAL HEALTH STUDIES; MENTAL HEALTH/SUBSTANCE ABUSE; ORGANIZATION AND MANAGEMENT; PSYCHOLOGY; SOCIAL DETERMINANTS OF HEALTH; SOCIOECONOMICS; STATISTICS; TOTAL QUALITY MANAGEMENT; MENTAL DISORDERS; STATISTICS AND NUMERICAL DATA;

DETERMINANTS OF HEALTH; HEALTH REFORM; INTERNATIONAL/GLOBAL HEALTH STUDIES; MENTAL HEALTH/SUBSTANCE ABUSE;

ADVISORY COMMITTEES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUSTRY; HEALTH POLICY; HUMANS; INTERDISCIPLINARY STUDIES; MENTAL DISORDERS; PSYCHOLOGY; QUALITY IMPROVEMENT; SOCIAL DETERMINANTS OF HEALTH; SOCIOECONOMIC FACTORS;

EID: 84877989709     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2011.0596     Document Type: Article

References (52)

1. Hyman SE. Can neuroscience be integrated into the DSM-V? Nat Rev Neurosci. 2007;8(9):725-32.
2. Carey B. Psychiatry manual drafters back down on diagnoses. New York Times. 2012 May 9.
3. Carey B. A tense compromise on defining disorders. New York Times. 2012 Dec 10.
4. Cesur R, Sabia JJ, Tekin E. The psychological costs of war: military combat and mental health. J Health Econ. 2013;32(1):51-65.
5. Malaspina D, Corcoran C, Kleinhaus KR, Perrin MC, Fennig S, Nahon D, et al. Acute maternal stress in pregnancy and schizophrenia in offspring: a cohort prospective study. BMC Psychiatry. 2008;8:71.
6. Perrin M, Kleinhaus K, Messinger J, Malaspina D. Critical periods and the developmental origins of disease: an epigenetic perspective of schizophrenia. Ann N Y Acad Sci. 2010;1204(Suppl):E8-13.
7. Philips CB. Medicine goes to school: teachers as sickness brokers for ADHD. PLoS Med. 2006;3(4):e182.
8. Woloshin S, Schwartz LM. Giving legs to restless legs: a case study of how the media helps make people sick. PloS Med. 2006;3(4):e170.
9. Tanne JH. American Psychiatric Association says no to industry funding for symposiums. BMJ. 2009;338:b1426.
10. Reiner PB. Conflict of interest in psychiatry-lecture by Thomas Insel at the 2010 Neuroethics Society Meeting [Internet]. Neuroethics at the Core [blog on the Internet]. 2010 Nov 15 [cited 2013 Mar 28]. Available from: http://neuroethicscanada.wordpress.com/2010/11/15/conflict-of-interest-in-psychiatrylecture-by-thomas-insel-at-the-2010-neuroethics-society-meeting/
11. Regier D, Narrow W, Kuhl E, Kupfer D. The conceptual development of DSM-V. Am J Psychiatry. 2009; 166(6):645-50.
12. Kupfer DJ, Regier DA, Kuhl EA. On the road to DSM-V and ICD-11. Eur Arch Psychiatry Clin Neurosci. 2008;258(Suppl 5):2-6.
13. Singh I. Beyond polemics: science and ethics of ADHD. Nat Rev Neurosci. 2008;9(12):957-64.
14. Okie S. ADHD in adults. N Engl J Med. 2006;354:2637-41.
15. Schwarz A, Cohen S. A.D.H.D. seen in 11% of U.S. children as diagnoses rise. New York Times. 2013 Mar 31.
16. Rose N. Disorders without borders? The expanding scope of psychiatric practice. BioSocieties. 2006;1: 465-84.
17. Alarcon RD, Becker AE, Lewis-Fernandez R, Like RC, Desai P, Foulkes E, et al. Issues for DSM-V: the role of culture in psychiatric diagnosis. J Nerv Ment Dis. 2009; 197(8):559-560.
18. Department of Health and Human Services. Mental health: culture, race, and ethnicity [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2001 Aug [cited 2013 Mar 29]. (Supplement to Mental Health: A Report of the Surgeon General). Available from: http://www.ncbi.nlm.nih.gov/books/n/mhcre/pdf/
19. Snowden LR, Hastings JF, Alvidrez J. Overrepresentation of black Americans in psychiatric inpatient care. Psychiatr Serv. 2009;60(6): 779-85.
20. Altemus M. Sex differences in depression and anxiety disorders: potential biological determinants. Horm Behav. 2006;50(4):534-8.
21. Trevillion K, Oram S, Feder G, Howard LM. Experiences of domestic violence and mental disorders: a systemic review and meta-analysis. PLoS One. 2012;7(12):e51740.
22. Blum LM, Stracuzzi NF. Gender in the Prozac nation: popular discourse and productive femininity. Gender and Society. 2004;18(3):269-86.
23. Addis ME, Mahalik JR. Men, masculinity, and the contexts of help seeking. Am Psychol. 2003;58(1): 5-14.
24. Möller-Leimkühler AM. Barriers to help-seeking by men: a review of sociocultural and clinical literature with particular reference to depression. J Affect Disord. 2002;71(1):1-9.
25. Mojtabai R, Olfson M. National trends in psychotropic medication polypharmacy in office-based psychiatry. Arch Gen Psychiatry. 2010; 67(1):26-36.
26. Boscarino JA, Kirchner HL, Hoffman SN, Sartorius J, Adams RE, Figley CR. Predicting future PTSD using a modified New York Risk Score: implications for patient screening and management. Minerva Psichiatr. 2012;53(1):47-59.
27. Meewisse ML, Olff M, Kleber R, Kitchiner NJ, Gersons BP. The course of mental health disorders after a disaster: predictors and comorbidity. J Trauma Stress. 2011; 24(4):405-13.
28. Phillips CJ, Leardmann CA, Gumbs GR, Smith B. Risk factors for posttraumatic stress disorder among deployed US male marines. BMC Psychiatry. 2010;10:52.
29. Rose G. Sick individuals and sick populations. Int J Epidemiol. 2001;30:427-32.
30. Link B, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995;35:80-94.
31. Liu KY, King M, Bearman PS. Social influence and the autism epidemic. AJS. 2010;115(5):1387-434.
32. Rogowski J, Karoly LA, Klerman JA, Inkelas M, Rowe M, Hirscher R. Final report for policy evaluation of the effect of the 1996 welfare reform legislation on SSI benefits for disabled children [Internet]. Santa Monica (CA): RAND Corporation; 2002 Mar [cited 2013 Mar 29]. (Document no. DRU-2559-SSA). Available from: http://www.rand.org/content/dam/rand/pubs/drafts/2005/DRU2559.pdf
33. Davies P, Iams H, Rupp K. The effect of welfare reform on SSA's disability programs: design of policy evaluation and early evidence. Soc Secur Bull. 2000;63(1):3-11.
34. Angell M. The illusions of psychiatry. New York Review of Books [serial on the Internet]. 2011 Jul 14 [cited 2013 Mar 29]. Available from http://www.nybooks.com/articles/archives/2011/jul/14/illusions-ofpsychiatry/?pagination=false
35. Leucht S, Corves C, Arbter D, Engel R, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a metaanalysis. Lancet. 2009;373:31-41.
36. Crystal S, Olfson M, Huang C, Pincus H, Gerhard T. Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff (Millwood). 2009; 28(5):770-81.
37. Constantine RJ, Tandon R, McPherson M, Andel R. Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6 years old who received antipsychotic treatment in Florida's Medicaid program. J Child Adolesc Psychopharmacol. 2011;21(1):79-84.
38. Seget S. Pharmaceutical market trends 2010-2014: key market forecasts and growth opportunities. 4th ed. London: URCH Publishing; 2010.
39. Wang SS. Psychiatric drug use spreads: pharmacy data show a big rise in antipsychotic and adult ADHD treatments. Wall Street Journal. 2011 Nov 16.
40. Gagnon MA, Lexchin J. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med. 2008;5(1):e1.
41. Grohol JM. DSM 5 sleep disorders overhaul. PsychCentral [blog on the Internet]. 2010 Jun 7 [cited 2013 Apr 8]. Available from: http://psychcentral.com/blog/archives/2010/06/07/dsm-5-sleep-disordersoverhaul/
42. Whalen J. How Glaxo marketed a malady to sell a drug: TV-ad blitz, physician onslaught are unleashed to inform about little-known disorder. Wall Street Journal. 2006 Oct 25.
43. Donohue JM, Cevasco M, Rosenthal M. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med. 2007;357:673-81.
44. Mintzes B. Direct to consumer advertising is medicalising normal human experience. BMJ. 2002;324: 908-11.
45. Alarcon RD, Bell CC, Kirmayer LJ, Lin KM, Ustiin B,Wisner KL. Beyond the funhouse mirrors: research agenda on culture and psychiatric diagnosis. Chapter 6 in: Kupfer DJ, First MF, Regier DA, editors. A research agenda for DSM-V. Washington (DC): American Psychiatric Association; 2002. p. 219-83.
46. Mezzich J, Kirmayrer L, Kleinman A, Fabrega H, Parron D, Good B, et al. The place of culture in DSM-IV. J Nerv and Ment Dis. 1999;187(8): 457-64.
47. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington (DC): APA; 2000.
48. Burling S. How do controversial revisions in psychiatry's guidebook make you feel? Philly.com [serial on the Internet]. 2012 May 5 [cited 2013 Mar 29]. Available from: http://articles.philly.com/2012-05-05/news/31573606_1_disruptivemood-dysregulation-disorder-dsm-5-mental-illness
49. Grand Challenges in Global Health [home page on the Internet]. Bethesda (MD): Grand Challenges; [cited 2013 Apr 4]. Available from: http://www.grandchallenges.org
50. Genome.gov. ELSI research program [home page on the Internet]. Bethesda (MD): Ethical, Legal and Social Implications Research Program; [last updated 2012 Dec 17; cited 2013 Apr 8]. Available from: http://www.genome.gov/10001618
51. Campbell Collaboration.What helps? What harms? Based on what evidence? Systematic reviews of the effects of interventions in education, crime and justice, and social welfare, to promote evidence-based decisionmaking [Internet]. Oslo: Campbell Collaboration; [cited 2013 Mar 29]. Available from: http://www.campbellcollaboration.org/artman2/uploads/1/C2_GeneralBrochure_low_May09.pdf
52. National Academy of Sciences. Division of behavioral and social sciences and education [home page on the Internet]. Washington (DC): The Academy; [cited 2013 Mar 29]. Available from: http://sites.nationalacademies.org/DBASSE/index.htm